Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Dermatology

  Free Subscription


11.09.2017

1 BMC Cancer
7 Br J Dermatol
1 Cancer
6 Cancer Res
1 Cutis
4 Int J Cancer
3 Int J Dermatol
4 J Cutan Pathol
1 J Dermatol
6 J Invest Dermatol
1 J R Soc Med
3 Lancet Oncol
2 Mycoses
1 N Engl J Med
5 Plast Reconstr Surg
46 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Cancer

  1. SEMEERE A, Freeman E, Wenger M, Glidden D, et al
    Updating vital status by tracking in the community among patients with epidemic Kaposi sarcoma who are lost to follow-up in sub-Saharan Africa.
    BMC Cancer. 2017;17:611.
    PubMed     Text format     Abstract available


    Br J Dermatol

  2. WEIDINGER S, Baurecht H, Schmitt J
    A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal.
    Br J Dermatol. 2017 Sep 4. doi: 10.1111/bjd.15827.
    PubMed     Text format     Abstract available

  3. DRUCKER AM, Eyerich K, de Bruin-Weller MS, Thyssen JP, et al
    Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement.
    Br J Dermatol. 2017 Sep 2. doi: 10.1111/bjd.15928.
    PubMed     Text format     Abstract available

  4. GUALENI B, Coulman SA, Shah D, Eng PF, et al
    Minimally-invasive and targeted therapeutic cell delivery to the skin using microneedle devices.
    Br J Dermatol. 2017 Sep 2. doi: 10.1111/bjd.15923.
    PubMed     Text format     Abstract available

  5. KRASUSKA M, Millings A, Lavda AC, Thompson AR, et al
    Compassion focussed self-help for skin conditions in individuals with insecure attachment: A pilot evaluation of the acceptability and potential effectiveness.
    Br J Dermatol. 2017 Sep 4. doi: 10.1111/bjd.15934.
    PubMed     Text format     Abstract available

  6. SATTLER EC, Ertl-Wagner B, Pellegrini C, Peris K, et al
    Cutaneous melanoma in Birt-Hogg-Dube syndrome - part of the clinical spectrum?
    Br J Dermatol. 2017 Sep 4. doi: 10.1111/bjd.15937.
    PubMed     Text format     Abstract available

  7. KESSELS JPHM, Kreukels H, Nelemans PJ, Roozeboom MH, et al
    Treatment of superficial basal cell carcinoma by topical photodynamic therapy with fractionated 5-aminolevulinic acid 20% versus two stage topical methylaminolevulinic acid: results of a randomized controlled trial.
    Br J Dermatol. 2017 Sep 8. doi: 10.1111/bjd.15967.
    PubMed     Text format     Abstract available

  8. WOLNER ZJ, Bajaj S, Flores E, Carrera C, et al
    Variation in dermoscopic features of basal cell carcinoma as a function of anatomic location and pigmentation status.
    Br J Dermatol. 2017 Sep 8. doi: 10.1111/bjd.15964.
    PubMed     Text format     Abstract available


    Cancer

  9. BENCI JL, Minn AJ, Vachani CC, Bach C, et al
    Survivorship care planning in skin cancer: An unbiased statistical approach to identifying patterns of care-plan use.
    Cancer. 2017 Sep 8. doi: 10.1002/cncr.30985.
    PubMed     Text format     Abstract available


    Cancer Res

  10. SUAREZ-CABRERA C, Quintana RM, Bravo A, Casanova ML, et al
    A transposon-based analysis reveals RASA1 is involved in triple negative breast cancer.
    Cancer Res. 2017 Jan 20. pii: canres.1586.2016.
    PubMed     Text format     Abstract available

  11. CHOY L, Hagenbeek TJ, Solon M, French D, et al
    Constitutive NOTCH3 Signaling Promotes the Growth of Basal Breast Cancers.
    Cancer Res. 2017;77:1439-1452.
    PubMed     Text format     Abstract available

  12. WU Y, Yu X, Yi X, Wu K, et al
    Aberrant phosphorylation of SMAD4 Thr277-mediated USP9x-SMAD4 interaction by free fatty acids promotes breast cancer metastasis.
    Cancer Res. 2017 Jan 23. pii: canres.2012.2016.
    PubMed     Text format     Abstract available

  13. ZHOU R, Pantel AR, Li S, Lieberman BP, et al
    [18F](2S,4R)4-Fluoroglutamine PET Detects Glutamine Pool Size Changes in Triple Negative Breast Cancer in Response to Glutaminase Inhibition.
    Cancer Res. 2017 Feb 15. pii: canres.1945.2016.
    PubMed     Text format     Abstract available

  14. ANJANAPPA M, Cardoso AA, Cheng L, Mohamad S, et al
    Individualized breast cancer characterization through single cell analysis of tumor and adjacent-normal cells.
    Cancer Res. 2017 Mar 1. pii: canres.3308.2016.
    PubMed     Text format     Abstract available

  15. VALENT P, Akin C, Hartmann K, Nilsson G, et al
    Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future.
    Cancer Res. 2017;77:1261-1270.
    PubMed     Text format     Abstract available


    Cutis

  16. TAYLOR SC, Barbosa V, Burgess C, Heath C, et al
    Hair and scalp disorders in adult and pediatric patients with skin of color.
    Cutis. 2017;100:31-35.
    PubMed     Text format     Abstract available


    Int J Cancer

  17. GADEYNE S, Menvielle G, Kulhanova I, Bopp M, et al
    The turn of the gradient? Educational differences in breast cancer mortality in 18 European populations during the 2000s.
    Int J Cancer. 2017 Mar 7. doi: 10.1002/ijc.30685.
    PubMed     Text format     Abstract available

  18. ROMAGUERA D, Gracia-Lavedan E, Molinuevo A, de Batlle J, et al
    Adherence to nutrition-based cancer prevention guidelines and breast, prostate and colorectal cancer risk in the MCC-Spain case-control study.
    Int J Cancer. 2017 Apr 5. doi: 10.1002/ijc.30722.
    PubMed     Text format     Abstract available

  19. THOGERSEN H, Moller B, Robsahm TE, Aaserud S, et al
    Comparison of cancer stage distribution in the immigrant and host populations of Norway, 1990-2014.
    Int J Cancer. 2017;141:52-61.
    PubMed     Text format     Abstract available

  20. LANG GT, Shi JX, Hu X, Zhang CH, et al
    The spectrum of BRCA mutations and characteristics of BRCA-associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next-generation sequencing.
    Int J Cancer. 2017;141:129-142.
    PubMed     Text format     Abstract available


    Int J Dermatol

  21. ZHANG S, Liu Y
    Langerhans cell histiocytosis in an adult female presenting with widespread confluent crusted papules and review of adult cases confined to skin.
    Int J Dermatol. 2017 Sep 7. doi: 10.1111/ijd.13722.
    PubMed     Text format    

  22. AMER M, Diab N, Soliman M, Amer A, et al
    Neonatal skin care: what should we do? A four-week follow-up randomized controlled trial at Zagazig University Hospitals.
    Int J Dermatol. 2017 Sep 7. doi: 10.1111/ijd.13735.
    PubMed     Text format     Abstract available

  23. ALGIERT-ZIELINSKA B, Batory M, Skubalski J, Rotsztejn H, et al
    Evaluation of the relation between lipid coat, transepidermal water loss, and skin pH.
    Int J Dermatol. 2017 Sep 7. doi: 10.1111/ijd.13726.
    PubMed     Text format     Abstract available


    J Cutan Pathol

  24. LOGHAVI S, Curry JL, Garcia-Manero G, Patel KP, et al
    Chronic myelomonocytic leukemia masquerading as cutaneous indeterminate dendritic cell tumor: expanding the spectrum of skin lesions in chronic myelomonocytic leukemia.
    J Cutan Pathol. 2017 Sep 8. doi: 10.1111/cup.13039.
    PubMed     Text format     Abstract available

  25. HORNA P, Shao H, Idrees A, Glass LF, et al
    Indeterminate dendritic cell neoplasm of the skin: A 2-case report and review of the literature.
    J Cutan Pathol. 2017 Sep 6. doi: 10.1111/cup.13017.
    PubMed     Text format     Abstract available

  26. TJARKS BJ, Pownell BR, Evans C, Thompson PA, et al
    Evaluation and comparison of staining patterns of factor XIIIa (AC-1A1), adipophilin, and GATA3 in sebaceous neoplasia.
    J Cutan Pathol. 2017 Sep 5. doi: 10.1111/cup.13037.
    PubMed     Text format     Abstract available

  27. TELLO T, Chiu NT, North JP
    Purpuric Agave Dermatitis.
    J Cutan Pathol. 2017 Sep 4. doi: 10.1111/cup.13035.
    PubMed     Text format     Abstract available


    J Dermatol

  28. MAURELLI M, Colato C, Girolomoni G, Gisondi P, et al
    Severe cutaneous aluminum reaction to quadrivalent human papillomavirus vaccine treated with cyclosporin.
    J Dermatol. 2017 Sep 4. doi: 10.1111/1346-8138.14020.
    PubMed     Text format    


    J Invest Dermatol

  29. JABBAR-LOPEZ ZK, Yiu ZZN, Ward V, Exton LS, et al
    Author Reply to: Letter to the Editor in Response to recently published article, 'Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis'.
    J Invest Dermatol. 2017 Aug 29. pii: S0022-202X(17)32833.
    PubMed     Text format    

  30. SCHMIDT MO, Garman KA, Lee YG, Zuo C, et al
    The Role of Fibroblast Growth Factor Binding Protein 1 in Skin Carcinogenesis and Inflammation.
    J Invest Dermatol. 2017 Aug 29. pii: S0022-202X(17)32825.
    PubMed     Text format     Abstract available

  31. AGAK GW, Kao S, Ouyang K, Qin M, et al
    Phenotype and antimicrobial activity of Th17 cells induced by Propionibacterium acnes strains associated with healthy and acne skin.
    J Invest Dermatol. 2017 Aug 29. pii: S0022-202X(17)32817.
    PubMed     Text format     Abstract available

  32. SUN M, Wang P, Okubo T, Orringer JS, et al
    Possible contribution of fibrocytes to increased type I collagen synthesis during the early stage of dermal wound repair in human skin.
    J Invest Dermatol. 2017 Aug 31. pii: S0022-202X(17)32835.
    PubMed     Text format    

  33. WEILAND D, Brachvogel B, Hornig-Do HT, Neuhaus JFG, et al
    Imbalance of Mitochondrial Respiratory Chain Complexes in the Epidermis Induces Severe Skin Inflammation.
    J Invest Dermatol. 2017 Aug 31. pii: S0022-202X(17)32834.
    PubMed     Text format     Abstract available

  34. HAUGH AM, Zhang B, Quan VL, Garfield EM, et al
    Distinct Patterns of Acral Melanoma Based on Site and Relative Sun Exposure.
    J Invest Dermatol. 2017 Sep 1. pii: S0022-202X(17)32917.
    PubMed     Text format     Abstract available


    J R Soc Med

  35. GARATTINI L, Padula A
    Immunotherapies for advanced melanoma: as promising as they are expensive?
    J R Soc Med. 2017 Jan 1:141076817731094. doi: 10.1177/0141076817731094.
    PubMed     Text format    


    Lancet Oncol

  36. DAVIES MA, Saiag P, Long GV
    Primary medical therapy for BRAFV600E-mutant melanoma brain metastases-is this good enough? - Authors' reply.
    Lancet Oncol. 2017;18:e509.
    PubMed     Text format    

  37. BAKER H
    Discontinuation of melanoma combination immunotherapy.
    Lancet Oncol. 2017 Sep 1. pii: S1470-2045(17)30668.
    PubMed     Text format    

  38. KRUSER TJ, Vogelbaum MA
    Primary medical therapy for BRAFV600E-mutant melanoma brain metastases-is this good enough?
    Lancet Oncol. 2017;18:e508.
    PubMed     Text format    


    Mycoses

  39. ABDOLRASOULI A, Armstrong-James D, Ryan L, Schelenz S, et al
    In vitro efficacy of disinfectants utilised for skin decolonization and environmental decontamination during a hospital outbreak with Candida auris.
    Mycoses. 2017 Sep 5. doi: 10.1111/myc.12699.
    PubMed     Text format     Abstract available

  40. TSENTEMEIDOU A, Vyzantiadis TA, Kyriakou A, Sotiriadis D, et al
    Prevalence of onychomycosis among patients with nail psoriasis who are not receiving immunosuppressive agents: Results of a pilot study.
    Mycoses. 2017 Sep 6. doi: 10.1111/myc.12681.
    PubMed     Text format     Abstract available


    N Engl J Med

  41. BISSELL DM, Anderson KE, Bonkovsky HL
    Porphyria.
    N Engl J Med. 2017;377:862-872.
    PubMed     Text format    


    Plast Reconstr Surg

  42. FLEURY C, Krishnan NM, Han KD, Nahabedian MY, et al
    Late Hematoma following Central Venous Port Removal.
    Plast Reconstr Surg. 2017;139:814e-815e.
    PubMed     Text format    

  43. BALLARD TNS, Zhong L, Momoh AO, Chung KC, et al
    Improved Rates of Immediate Breast Reconstruction at Safety Net Hospitals.
    Plast Reconstr Surg. 2017;140:1-10.
    PubMed     Text format     Abstract available

  44. DENT BL, Miller JA, Eden DJ, Swistel A, et al
    Tumor-to-Nipple Distance as a Predictor of Nipple Involvement: Expanding the Inclusion Criteria for Nipple-Sparing Mastectomy.
    Plast Reconstr Surg. 2017;140:1e-8e.
    PubMed     Text format     Abstract available

  45. LENNOX PA, Bovill ES, Macadam SA
    Evidence-Based Medicine: Alloplastic Breast Reconstruction.
    Plast Reconstr Surg. 2017;140:94e-108e.
    PubMed     Text format     Abstract available

  46. JONES CM, Rothermel AT, Mackay DR
    Evidence-Based Medicine: Wound Management.
    Plast Reconstr Surg. 2017;140:201e-216e.
    PubMed     Text format     Abstract available


    PLoS One

  47. BASU A, Sridharan S
    Regulation of anti-apoptotic Bcl-2 family protein Mcl-1 by S6 kinase 2.
    PLoS One. 2017;12:e0173854.
    PubMed     Text format     Abstract available

  48. TOSCANI AM, Sampayo RG, Barabas FM, Fuentes F, et al
    Distinct ErbB2 receptor populations differentially interact with beta1 integrin in breast cancer cell models.
    PLoS One. 2017;12:e0174230.
    PubMed     Text format     Abstract available

  49. ZAK M, Biskup M, Macek P, Krol H, et al
    Identifying predictive motor factors for falls in post-menopausal breast cancer survivors.
    PLoS One. 2017;12:e0173970.
    PubMed     Text format     Abstract available

  50. KIM YM, Kim J, Han Y, Jeon BH, et al
    Short-term effects of weather and air pollution on atopic dermatitis symptoms in children: A panel study in Korea.
    PLoS One. 2017;12:e0175229.
    PubMed     Text format     Abstract available

  51. HWANG DJ, Lee KM, Park MS, Choi SH, et al
    Association between diabetic foot ulcer and diabetic retinopathy.
    PLoS One. 2017;12:e0175270.
    PubMed     Text format     Abstract available

  52. KIM MS, Kim SY, Kim JH, Park B, et al
    Depression in breast cancer patients who have undergone mastectomy: A national cohort study.
    PLoS One. 2017;12:e0175395.
    PubMed     Text format     Abstract available

  53. DEINLEIN T, Arzberger E, Zalaudek I, Massone C, et al
    Dermoscopic characteristics of melanoma according to the criteria "ulceration" and "mitotic rate" of the AJCC 2009 staging system for melanoma.
    PLoS One. 2017;12:e0174871.
    PubMed     Text format     Abstract available

  54. SAGHAFIPOUR A, Vatandoost H, Zahraei-Ramazani AR, Yaghoobi-Ershadi MR, et al
    Control of zoonotic cutaneous leishmaniasis vector, Phlebotomus papatasi, using attractive toxic sugar baits (ATSB).
    PLoS One. 2017;12:e0173558.
    PubMed     Text format     Abstract available

  55. MASUDA T, Song W, Nakanishi H, Lei W, et al
    Rare cell isolation and recovery on open-channel microfluidic chip.
    PLoS One. 2017;12:e0174937.
    PubMed     Text format     Abstract available

  56. GOHRING AR, Reuter S, Clement JH, Cheng X, et al
    Human microRNA-299-3p decreases invasive behavior of cancer cells by downregulation of Oct4 expression and causes apoptosis.
    PLoS One. 2017;12:e0174912.
    PubMed     Text format     Abstract available

  57. HENG J, Guo X, Wu W, Wang Y, et al
    Integrated analysis of promoter mutation, methylation and expression of AKT1 gene in Chinese breast cancer patients.
    PLoS One. 2017;12:e0174022.
    PubMed     Text format     Abstract available

  58. HE X, Ye F, Zhao B, Tang H, et al
    Risk factors for delay of adjuvant chemotherapy in non-metastatic breast cancer patients: A systematic review and meta-analysis involving 186982 patients.
    PLoS One. 2017;12:e0173862.
    PubMed     Text format     Abstract available

  59. ROCHA-BRISCHILIARI SC, Oliveira RR, Andrade L, Brischiliari A, et al
    The Rise in Mortality from Breast Cancer in Young Women: Trend Analysis in Brazil.
    PLoS One. 2017;12:e0168950.
    PubMed     Text format     Abstract available

  60. SIMON M, Mesmar F, Helguero L, Williams C, et al
    Genome-wide effects of MELK-inhibitor in triple-negative breast cancer cells indicate context-dependent response with p53 as a key determinant.
    PLoS One. 2017;12:e0172832.
    PubMed     Text format     Abstract available

  61. BONSANG-KITZIS H, Mouttet-Boizat D, Guillot E, Feron JG, et al
    Medico-economic impact of MSKCC non-sentinel node prediction nomogram for ER-positive HER2-negative breast cancers.
    PLoS One. 2017;12:e0169962.
    PubMed     Text format     Abstract available

  62. AZAD AK, Lawen A, Keith JM
    Bayesian model of signal rewiring reveals mechanisms of gene dysregulation in acquired drug resistance in breast cancer.
    PLoS One. 2017;12:e0173331.
    PubMed     Text format     Abstract available

  63. HSU FG, Hsieh YW, Sheu MJ, Lin CC, et al
    Tamoxifen use and acute pancreatitis: A population-based cohort study.
    PLoS One. 2017;12:e0173089.
    PubMed     Text format     Abstract available

  64. LIU Y, Gu F, Liang J, Dai X, et al
    The efficacy and toxicity profile of metronomic chemotherapy for metastatic breast cancer: A meta-analysis.
    PLoS One. 2017;12:e0173693.
    PubMed     Text format     Abstract available

  65. NG CG, Mohamed S, Kaur K, Sulaiman AH, et al
    Perceived distress and its association with depression and anxiety in breast cancer patients.
    PLoS One. 2017;12:e0172975.
    PubMed     Text format     Abstract available

  66. STEPHEN J, Yokoyama T, Tolman NJ, O'Brien KJ, et al
    Cellular and molecular defects in a patient with Hermansky-Pudlak syndrome type 5.
    PLoS One. 2017;12:e0173682.
    PubMed     Text format     Abstract available

  67. GROS A, Laharanne E, Vergier M, Prochazkova-Carlotti M, et al
    TP53 alterations in primary and secondary Sezary syndrome: A diagnostic tool for the assessment of malignancy in patients with erythroderma.
    PLoS One. 2017;12:e0173171.
    PubMed     Text format     Abstract available

  68. KLEBANER D, Hamilton-Dutoit S, Ahern T, Crawford A, et al
    Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patients.
    PLoS One. 2017;12:e0171453.
    PubMed     Text format     Abstract available

  69. EL GUERRAB A, Cayre A, Kwiatkowski F, Privat M, et al
    Quantification of hypoxia-related gene expression as a potential approach for clinical outcome prediction in breast cancer.
    PLoS One. 2017;12:e0175960.
    PubMed     Text format     Abstract available

  70. PILEGGI SM, Jordan H, Clennon JA, Whitney E, et al
    Landscape and environmental influences on Mycobacterium ulcerans distribution among aquatic sites in Ghana.
    PLoS One. 2017;12:e0176375.
    PubMed     Text format     Abstract available

  71. DOU R, Liu Z, Yuan X, Xiangfei D, et al
    PAMs ameliorates the imiquimod-induced psoriasis-like skin disease in mice by inhibition of translocation of NF-kappaB and production of inflammatory cytokines.
    PLoS One. 2017;12:e0176823.
    PubMed     Text format     Abstract available

  72. KIM GR, Choi JS, Han BK, Ko EY, et al
    Combination of shear-wave elastography and color Doppler: Feasible method to avoid unnecessary breast excision of fibroepithelial lesions diagnosed by core needle biopsy.
    PLoS One. 2017;12:e0175380.
    PubMed     Text format     Abstract available

  73. MARTINEZ-CANALES S, Cifuentes F, Lopez De Rodas Gregorio M, Serrano-Oviedo L, et al
    Transcriptomic immunologic signature associated with favorable clinical outcome in basal-like breast tumors.
    PLoS One. 2017;12:e0175128.
    PubMed     Text format     Abstract available

  74. KANOMATA N, Matsuura S, Nomura T, Kurebayashi J, et al
    Preparation of a novel antiserum to aromatase with high affinity and specificity: Its clinicopathological significance on breast cancer tissue.
    PLoS One. 2017;12:e0177439.
    PubMed     Text format     Abstract available

  75. TAKEUCHI H, Kawanaka H, Fukuyama S, Kubo N, et al
    Comparison of the prognostic values of preoperative inflammation-based parameters in patients with breast cancer.
    PLoS One. 2017;12:e0177137.
    PubMed     Text format     Abstract available

  76. LAKATOS E, Salehi-Reyhani A, Barclay M, Stumpf MPH, et al
    Protein degradation rate is the dominant mechanism accounting for the differences in protein abundance of basal p53 in a human breast and colorectal cancer cell line.
    PLoS One. 2017;12:e0177336.
    PubMed     Text format     Abstract available

  77. PIO GM, Xia Y, Piaseczny MM, Chu JE, et al
    Soluble bone-derived osteopontin promotes migration and stem-like behavior of breast cancer cells.
    PLoS One. 2017;12:e0177640.
    PubMed     Text format     Abstract available

  78. GININDZA TG, Sartorius B, Dlamini X, Ostensson E, et al
    Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in Swaziland.
    PLoS One. 2017;12:e0177762.
    PubMed     Text format     Abstract available

  79. LIU Z, He K, Ma Q, Yu Q, et al
    Autophagy inhibitor facilitates gefitinib sensitivity in vitro and in vivo by activating mitochondrial apoptosis in triple negative breast cancer.
    PLoS One. 2017;12:e0177694.
    PubMed     Text format     Abstract available

  80. GOODE G, Gunda V, Chaika NV, Purohit V, et al
    MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer.
    PLoS One. 2017;12:e0176820.
    PubMed     Text format     Abstract available

  81. SUN J, Feng X, Zhu Q, Lin W, et al
    Analgesic effect of perineural magnesium sulphate for sciatic nerve block for diabetic toe amputation: A randomized trial.
    PLoS One. 2017;12:e0176589.
    PubMed     Text format     Abstract available

  82. BARTEL CA, Jackson MW
    HER2-positive breast cancer cells expressing elevated FAM83A are sensitive to FAM83A loss.
    PLoS One. 2017;12:e0176778.
    PubMed     Text format     Abstract available

  83. ZHOU W, Song F, Wu Q, Liu R, et al
    miR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5.
    PLoS One. 2017;12:e0176395.
    PubMed     Text format     Abstract available

  84. BAUER D, Redmon N, Mazzio E, Soliman KF, et al
    Apigenin inhibits TNFalpha/IL-1alpha-induced CCL2 release through IKBK-epsilon signaling in MDA-MB-231 human breast cancer cells.
    PLoS One. 2017;12:e0175558.
    PubMed     Text format     Abstract available

  85. LU T, Gu M, Zhao Y, Zheng X, et al
    Autophagy contributes to falcarindiol-induced cell death in breast cancer cells with enhanced endoplasmic reticulum stress.
    PLoS One. 2017;12:e0176348.
    PubMed     Text format     Abstract available

  86. WELINDER C, Pawlowski K, Szasz AM, Yakovleva M, et al
    Correlation of histopathologic characteristics to protein expression and function in malignant melanoma.
    PLoS One. 2017;12:e0176167.
    PubMed     Text format     Abstract available

  87. VIANA MVC, Figueiredo H, Ramos R, Guimaraes LC, et al
    Comparative genomic analysis between Corynebacterium pseudotuberculosis strains isolated from buffalo.
    PLoS One. 2017;12:e0176347.
    PubMed     Text format     Abstract available

  88. MOHD MUJAR NM, Dahlui M, Emran NA, Abdul Hadi I, et al
    Complementary and alternative medicine (CAM) use and delays in presentation and diagnosis of breast cancer patients in public hospitals in Malaysia.
    PLoS One. 2017;12:e0176394.
    PubMed     Text format     Abstract available

  89. BICKELHAUPT S, Steudle F, Paech D, Mlynarska A, et al
    On a fractional order calculus model in diffusion weighted breast imaging to differentiate between malignant and benign breast lesions detected on X-ray screening mammography.
    PLoS One. 2017;12:e0176077.
    PubMed     Text format     Abstract available

  90. CHALISE P, Fridley BL
    Integrative clustering of multi-level 'omic data based on non-negative matrix factorization algorithm.
    PLoS One. 2017;12:e0176278.
    PubMed     Text format     Abstract available

  91. LI X, Brock GN, Rouchka EC, Cooper NGF, et al
    A comparison of per sample global scaling and per gene normalization methods for differential expression analysis of RNA-seq data.
    PLoS One. 2017;12:e0176185.
    PubMed     Text format     Abstract available

  92. MATOSSIAN MD, Elliott S, Hoang VT, Burks HE, et al
    Novel application of the published kinase inhibitor set to identify therapeutic targets and pathways in triple negative breast cancer subtypes.
    PLoS One. 2017;12:e0177802.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dermatology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: